Klaus Herrlinger
Impact in
- Microbiology top 1%
- Antimicrobial Peptides and Activities
- Genetics top 1%
- Inflammatory Bowel Disease
Papers in
- Genetics 44
- Inflammatory Bowel Disease 44
- Co-authors
- Eduard F. StangeKlaus FellermannJan WehkampKatja RothfussMatthias SchwabAlexander TemlElke SchaeffelerD Ludwig
- Journals
- Alimentary Pharmacology & Therapeutics (7 papers)Inflammatory Bowel Diseases (6 papers)Gastroenterology (5 papers)World Journal of Gastroenterology (2 papers)Journal of Crohn s and Colitis (2 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Klaus Herrlinger
49 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 111
- Microbiology 383
- Genetics 1.3k
- Immunology 608
- Epidemiology 873
- Gastroenterology 136
Countries citing papers authored by Klaus Herrlinger
This map shows the geographic impact of Klaus Herrlinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Herrlinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Herrlinger more than expected).
Fields of papers citing papers by Klaus Herrlinger
This network shows the impact of papers produced by Klaus Herrlinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Herrlinger. The network helps show where Klaus Herrlinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Klaus Herrlinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2016 | 124 | |
| 5 | 2014 | 0 | |
| 6 | 2010 | 18 | |
| 7 | 2010 | 19 | |
| 8 | 2009 | 101 | |
| 9 | 2009 | 221 | |
| 10 | 2009 | 12 | |
| 11 | 2006 | 252 | |
| 12 | 2006 | 48 | |
| 13 | 2006 | 11 | |
| 14 | 2005 | 115 | |
| 15 | 2005 | 62 | |
| 16 | 2004 | 11 | |
| 17 | 2003 | 51 | |
| 18 | 2002 | 123 | |
| 19 | 2001 | 51 | |
| 20 | 2000 | 31 |
About Klaus Herrlinger
Klaus Herrlinger is a scholar working on Genetics, Gastroenterology, Microbiology, Epidemiology and Immunology, having authored 57 papers that have together received 2.6k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (44 papers), Microscopic Colitis (24 papers), Autoimmune and Inflammatory Disorders (8 papers), Antimicrobial Peptides and Activities (7 papers), Acute Lymphoblastic Leukemia research (7 papers), Eosinophilic Esophagitis (6 papers), Autoimmune and Inflammatory Disorders Research (4 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). The work is most often cited by research in Microbiology (383 citations), Genetics (1.3k citations), Immunology (608 citations), Epidemiology (873 citations) and Gastroenterology (136 citations). Klaus Herrlinger has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Eduard F. Stange, Klaus Fellermann, Jan Wehkamp, Katja Rothfuss, Matthias Schwab, Alexander Teml, Elke Schaeffeler, D Ludwig, Jens M. Schroeder and Michael Weichenthal. Their work appears in journals such as Alimentary Pharmacology & Therapeutics, Inflammatory Bowel Diseases, Gastroenterology, World Journal of Gastroenterology and Journal of Crohn s and Colitis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.